Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
Daniel Shae, Kyle W. Becker, Plamen P. Christov, et al.
Nature Nanotechnology (2019) Vol. 14, Iss. 3, pp. 269-278
Open Access | Times Cited: 548

Showing 1-25 of 548 citing articles:

Engineering precision nanoparticles for drug delivery
Michael J. Mitchell, Margaret M. Billingsley, Rebecca M. Haley, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 2, pp. 101-124
Open Access | Times Cited: 5255
Smart cancer nanomedicine
Roy van der Meel, Einar Sulheim, Yang Shi, et al.
Nature Nanotechnology (2019) Vol. 14, Iss. 11, pp. 1007-1017
Open Access | Times Cited: 1026
Targeting STAT3 in Cancer Immunotherapy
Sailan Zou, Qiyu Tong, Bowen Liu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 723
Enhancing cancer immunotherapy with nanomedicine
Darrell J. Irvine, Eric L. Dane
Nature reviews. Immunology (2020) Vol. 20, Iss. 5, pp. 321-334
Open Access | Times Cited: 681
Improving cancer immunotherapy through nanotechnology
Michael S. Goldberg
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 587-602
Closed Access | Times Cited: 529
Amplifying STING activation by cyclic dinucleotide–manganese particles for local and systemic cancer metalloimmunotherapy
Xiaoqi Sun, Yu Zhang, Jiaqian Li, et al.
Nature Nanotechnology (2021) Vol. 16, Iss. 11, pp. 1260-1270
Open Access | Times Cited: 511
cGAS-STING, an important pathway in cancer immunotherapy
Minlin Jiang, Peixin Chen, Lei Wang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 421
Combining Nanomedicine and Immunotherapy
Yang Shi, Twan Lammers
Accounts of Chemical Research (2019) Vol. 52, Iss. 6, pp. 1543-1554
Open Access | Times Cited: 390
Brief update on endocytosis of nanomedicines
Siddharth Patel, Jeonghwan Kim, Marco Herrera-Barrera, et al.
Advanced Drug Delivery Reviews (2019) Vol. 144, pp. 90-111
Open Access | Times Cited: 320
The cGAS–STING pathway and cancer
Natasha Samson, Andrea Ablasser
Nature Cancer (2022) Vol. 3, Iss. 12, pp. 1452-1463
Closed Access | Times Cited: 303
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
Lang Rao, Lei Wu, Zhida Liu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 291
Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
Anping Li, Ming Yi, Shuang Qin, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 288
Biomimetic Nanotechnology toward Personalized Vaccines
Jiarong Zhou, Ashley V. Kroll, Maya Holay, et al.
Advanced Materials (2019) Vol. 32, Iss. 13
Open Access | Times Cited: 288
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Shaojun Peng, Fengfeng Xiao, Meiwan Chen, et al.
Advanced Science (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 280
Proton-driven transformable nanovaccine for cancer immunotherapy
Ningqiang Gong, Yuxuan Zhang, Xucong Teng, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 12, pp. 1053-1064
Open Access | Times Cited: 255
Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel
Feihu Wang, Hao Su, Dongqing Xu, et al.
Nature Biomedical Engineering (2020) Vol. 4, Iss. 11, pp. 1090-1101
Open Access | Times Cited: 243
cGAS-STING pathway in cancer biotherapy
Yang Wang, Jingwen Luo, Aqu Alu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 243
Bacteria‐Based Cancer Immunotherapy
Xuehui Huang, Jingmei Pan, Funeng Xu, et al.
Advanced Science (2021) Vol. 8, Iss. 7
Open Access | Times Cited: 237
Designing spatial and temporal control of vaccine responses
Gillie A. Roth, Vittoria C. T. M. Picece, Ben S. Ou, et al.
Nature Reviews Materials (2021) Vol. 7, Iss. 3, pp. 174-195
Open Access | Times Cited: 228
Polymeric Nanoparticles for Drug Delivery
Maximilian A. Beach, Umeka Nayanathara, Yanting Gao, et al.
Chemical Reviews (2024) Vol. 124, Iss. 9, pp. 5505-5616
Closed Access | Times Cited: 226
Prolonged activation of innate immune pathways by a polyvalent STING agonist
Suxin Li, Min Luo, Zhaohui Wang, et al.
Nature Biomedical Engineering (2021) Vol. 5, Iss. 5, pp. 455-466
Open Access | Times Cited: 225
STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity
Eric L. Dane, Alexis Belessiotis‐Richards, Coralie M. Backlund, et al.
Nature Materials (2022) Vol. 21, Iss. 6, pp. 710-720
Open Access | Times Cited: 215
Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response
Dongshan Wan, Wei Jiang, Junwei Hao
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 211
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 211
Controlling timing and location in vaccines
Darrell J. Irvine, Aereas Aung, Murillo Silva
Advanced Drug Delivery Reviews (2020) Vol. 158, pp. 91-115
Open Access | Times Cited: 208
Page 1 - Next Page

Scroll to top